TORONTO–(BUSINESS WIRE)– #ARDS–FDA clears IND for Pegevongitide (AV-001), a Tie2 agonist targeting vascular leak, to evaluate acute resuscitation in severe burns.
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients
